Document is current
Any future updates will be listed below
-
Authors
Kaur, Harsimar B. https://orcid.org/0000-0002-1178-7596
Vidotto, Thiago
Mendes, Adrianna A.
Salles, Daniela C.
Isaacs, William B.
Antonarakis, Emmanuel S.
Lotan, Tamara L.
-
Funding
Funding for this research was provided by:
Prostate Cancer Foundation
National Cancer Institute (SPORE P50 CA58236, 5P30 CA006973-52)
- License Information
-
More Information
Article History
Received: 20 April 2021
Accepted: 5 September 2021
First Online: 17 September 2021
Declarations
:
: TLL has received research support from Roche, DeepBio, and Myriad Biosciences. ESA has served as a paid consultant/advisor for Janssen, Pfizer, Sanofi, Merck, Bristol-Myers Squibb, AstraZeneca, Clovis, Eli Lilly, and Amgen; has received research funding to his institution from Janssen, Johnson & Johnson, Sanofi, Genentech, Novartis, Merck, Bristol-Myers Squibb, AstraZeneca and Constellation; and is a co-inventor of a biomarker technology that has been licensed to Qiagen.
: Study was conducted with Johns Hopkins Institutional Review Board approval.
: Study was conducted under a waiver of consent on de-identified retrospectively collected cases.
: Study was conducted under a waiver of consent on de-identified retrospectively collected cases.
